Serogroup W-135 Meningococcal Disease during the Hajj, 2000

An outbreak of serogroup W-135 meningococcal disease occurred during the 2000 Hajj in Saudi Arabia. Disease was reported worldwide in Hajj pilgrims and their close contacts; however, most cases were identified in Saudi Arabia. Trends in Saudi meningococcal disease were evaluated and the epidemiology of Saudi cases from this outbreak described. Saudi national meningococcal disease incidence data for 1990 to 2000 were reviewed; cases from January 24 to June 5, 2000 were retrospectively reviewed. The 2000 Hajj outbreak consisted of distinct serogroup A and serogroup W-135 outbreaks. Of 253 identified cases in Saudi Arabia, 161 (64%) had serogroup identification; serogroups W-135 and A caused 93 (37%) and 60 (24%) cases with attack rates of 9 and 6 cases per 100,000 population, respectively. The 2000 Hajj outbreak was the first large serogroup W-135 meningococcal disease outbreak identified worldwide. Enhanced surveillance for serogroup W-135, especially in Africa, is essential to control this emerging epidemic disease

Knowledge and barriers to screening for colorectal cancer among individuals aged 40 years or older visiting primary healthcare clinics in Al-Khobar, Eastern Province

BACKGROUND: Colorectal cancer (CRC) ranks third as the most common cancer in the world and the 4th most common cause of deaths from cancer. In Saudi Arabia, CRC is the most common cancer in males and the third most common in females. Early screening reduces the risk of CRC and death. However, there is a lack of awareness of CRC screening in Saudi Arabia. The objective of this study was to determine the knowledge, practices, and barriers to CRC screening using the Health Belief Model (HBM). MATERIALS AND METHODS: This study enrolled Saudis aged 40 years or older visiting PHCCs in Al-Khobar. Data were collected using a self-administered questionnaire or a direct interview of the selected participants. Information sought included sociodemographics, past CRC screening, CRC knowledge, and HBM items. Data analysis was done using SPSS; the Chi-squared test and ANOVA were used to determine statistical significance. RESULTS: A total of 206 of the individuals approached completed the questionnaire. The average age was 51.1 years, and 51% were males. Only 10% reported that a physician had provided information on CRC prevention or discussed/recommended screening for CRC, and 10% had undergone screening for CRC. Seventy-five percent of respondents had heard of CRC, and 74% said that CRC was preventable. Regarding the HBM, no significant difference in the mean scores for perceived susceptibility, perceived severity, self-efficacy, and benefits of CRC screening was found by age groups. The mean score for perceived severity was higher for females than males. About 60% of participants were extremely likely to have a screening test for CRC done on the day if recommended by the doctor. CONCLUSION: The knowledge and awareness of CRC screening of the targeted sample is inadequate. Individuals with higher perceived susceptibility, severity of CRC, and perceived benefit of the screening tests were more willing to undergo the test. The highest perceived barrier was having no symptoms, and the lowest was “getting a stool test is too much of a hassle.” These findings underline the importance of having a national screening program and campaigns to deal with the concerns of people and raise awareness of CRC

Green synthesis of Cr2O3 nanoparticles by Cassia fistula, their electrochemical and antibacterial potential

Chromium oxide (Cr2O3) nanoparticles (NPs) find applications in modern science and technology due to their chemical stabilities, high-density corners and magnetic/electrical/catalytic properties. Current studies were performed to produce the (Cr2O3)aq and (Cr2O3)et NPs by treating chromium acetate with the aqueous and ethanolic extracts, respectively of Cassia fistula leaves; the same reaction was also performed in the presence of NaOH to yield the (Cr2O3)aqNa and (Cr2O3)etNa NPs, respectively. The synthesized NPs were characterized by XRD, FTIR, Raman spectroscopy, UV–Vis spectroscopy, SEM, TGA and DSC analysis and examined for their electrochemical properties. Their antibacterial potential was tested by biofilm inhibition and agar well diffusion methods. XRD studies revealed that Cr2O3 NPs possessed hexagonal crystal structures with the crystallite sizes of 14.85 to 23.90 nm; the lowest size (14.85 nm) was possessed by (Cr2O3)et. FTIR and Raman spectroscopies verified the +3-oxidation state of chromium and corresponding Cr-O and Cr=O vibrations. Raman spectroscopy determined A1g vibration modes (540.50–557.07 cm−1) with rhombohedral Cr2O3 structure, high degree of crystallinity and existence of Cr3+ ions in octahedral coordination whereas Eg vibration modes were displayed at 306.04–350.87 cm−1 and 602.47–613.81 cm−1. UV–Visible spectroscopy has shown band gaps in the range of 4.06–4.40 eV. The SEM images demonstrated the spherical morphology with a high degree of agglomeration between fine particles. The synthesized NPs exhibited good thermal stabilities up to 600 °C. The CV curves displayed the oxidation–reduction peaks and reversible behavior whereas GCD curve indicated the possible energy storage applications of NPs. (Cr2O3)aqNa NPs showed the highest specific capacitance (234.35 mAhg−1) at 1 mA current density. The biofilm inhibitions of the investigated NPs were comparable to those of the standard antibacterial drug (ciprofloxacin); the activity of (Cr2O3)etNa was found even better than that of ciprofloxacin. The NPs were more active against Escherichia coli (Gram-negative) as compared to those against Staphylococcus aureus (Gram-positive)